Ger Brennan, who runs the Irish operation of MSD, is Brexit-ready and focusing on other issues
AdventHealth deal will see Irish companies get direct access to key market leaders
WEIF remains co-investor in three of Malin’s four main investee companies
World’s top cancer drug group sees China sales grow more than 50% in a year
Woodford Equity Income Fund enters liquidation over issues revealed in June
Belfast health tech company will bring Modius Sleep device to US market later this year
Figures cover year when Vicky Phelan case in spotlight and screening programme issues
Despite profits slip, Teva says Waterford site is one of the most successful across the group
Pentwater bought shares at 60% discount to Malin’s ‘intrinsic value’
Troubled asset manager thought to have sold 1.6m shares earlier this week
Pharmaceuticals group employs 500 people in Ireland working on rare disease therapies
FDA has accepted filing for pre-market approval application
Company plans to ramp up commercialisation of tinnitus treatment
Pharma services business completed reverse takeover of Venn Life Sciences in June
Company submits application for pre-market approval to US regulator
Interview of the Week: Ger Rabbette, Uniphar
Roche posted pretax losses of €1.7m in 2018 and is set to make 132 employees redundant
Company says proceeds to be used to repay BoI loan facility and invest in Irish portfolio
Invalid email or password.
